Activities of recurrent cancer immunity steps including the release of cancer cell antigen, CD8+ T-cell recruiting, dendritic cell recruiting, macrophage recruiting, T-helper 17 (Th17) cell recruiting, T-cell infiltration into tumors and killing of cancer cells were significantly higher in MIP subtype (Supplementary Figures 11A–C). This evidence concerns the gene CD8A and cancer.